Drug-Induced Interstitial Lung Diseases

Abstract

Drug-induced interstitial lung disease (DI-ILD) is an increasingly common cause of morbidity and mortality as the list of culprit drugs continues to grow. Unfortunately, DI-ILD is difficult to study, diagnose, prove, and manage. This article attempts to raise awareness of the challenges in DI-ILD and discusses the current clinical landscape.

Keywords: Chest imaging; Drug-induced interstitial lung disease; Iatrogenic; Infiltrative lung disease; Interstitial lung disease; Lung toxicity; Pneumonitis; Pulmonary toxicity; Respiratory system.